Printer Friendly

WYETH-AYERST LABORATORIES TO SPONSORAMERICAN ACADEMY OF PEDIATRICS (AAP) CATCH PROGRAM

 PHILADELPHIA, Feb. 1 /PRNewswire/ -- Wyeth-Ayerst Laboratories will become a major sponsor of the American Academy of Pediatrics (AAP) Community Access to Child Health (CATCH) program.
 The purpose of CATCH is to make quality health care available for all the nation's children.
 Through CATCH, local pediatricians spearhead efforts in their own communities to identify the health care needs of children and to find solutions. Together with parents, educators, business leaders, policy makers, and other health professionals, they develop unique programs that increase the access of local children to quality health care. The CATCH program follows the principle that local people solve local problems and that pediatricians can be the leaders for improving access to health care for children.
 CATCH pediatricians encourage other pediatricians to initiate community-based health care programs for children by sharing their own successful experiences through meetings, written materials and other publicity. Currently, there are more than 60 local CATCH programs in cities and neighborhoods across the country.
 "CATCH helps pediatricians do what they want to do most -- to take care of children," said F. Edwards Rushton, M.D., F.A.A.P., director of CATCH. "It gets them into the trenches and provides them with the know- how to eliminate the obstacles that prevent children from getting medical attention."
 "The CATCH program is a top priority for the Academy," said Joe M. Sanders, AAP associate executive director, "because we believe every child has a right to the best possible health care. With the resources provided through our partnership with Wyeth-Ayerst Laboratories, we will be able to expand the program, bringing CATCH to more pediatricians, more communities, and, most importantly, to more children."
 "We share the Academy's commitment to the health of all children and its belief in CATCH," said David Dodd, vice president and general manager of Wyeth Pediatrics. "We welcome the opportunity to be part of such an important program."
 The CATCH program was developed and continues to be supported by a grant from the Robert Wood Johnson Foundation.
 The American Academy of Pediatrics is an organization of 45,000 pediatricians dedicated to the health, safety and well-being of infants, children, adolescents and young adults.
 Wyeth-Ayerst Laboratories, a division of American Home Products Corporation (NYSE: AHP), is a major research-oriented pharmaceutical company with leading products in the areas of female health care, cardiovascular and metabolic disease therapies, central nervous system drugs, anti-inflammatory agents, vaccines and infant nutritionals.
 /delval/
 -0- 2/1/93
 /CONTACT: Audrey Ashby of Wyeth-Ayerst Laboratories, 215-971-5823/
 (AHP)


CO: Wyeth-Ayerst Laboratories; American Academy of Pediatrics ST: Pennsylvania IN: HEA SU:

LJ-MK -- PH006 -- 1168 02/01/93 08:55 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 1, 1993
Words:434
Previous Article:ENERGIE-VERSORGUNG NIEDEROSTERREICH ANNOUNCES FIRST QUARTER RESULTS
Next Article:TRM COPY CENTERS CORP. ANNOUNCES RESULTS FOR THE SECOND QUARTER OF FISCAL 1993
Topics:


Related Articles
BURROUGHS WELLCOME CO. AND WYETH-AYERST TO CO-PROMOTE NEW TREATMENT FOR CHICKENPOX
WYETH-AYERST AND PANLABS SIGN RESEARCH COLLABORATION
WYETH-AYERST LABORATORIES RESPONDS TO SENATE AGING COMMITTEE REPORT
HEALTH-CARE PROFESSIONAL NETWORK FOR THE NORPLANT SYSTEM (LEVONORGESTREL IMPLANTS) ESTABLISHED AS QUICK REFERRAL FOR PATIENTS
WYETH-AYERST LABORATORIES AWARDS PHYSICIANS FOR SIGNIFICANT PROFESSIONAL ACHIEVEMENT
Lederle Files With FDA, Seeking Licensure for Use of Combination DTAP-Hib Vaccine in Children
FDA Decision Recognizes Complexity of Premarin(R) (conjugated estrogens tablets, USP)
FDA Advisory Committee Concludes That First Vaccine for Use in Prevention of Rotavirus Gastroenteritis in Infants is Safe and Effective
$500 Million Products Liability Lawsuit Filed Against American Home Products Corporation for Permanent Brain Damage Allegedly Caused by the Use of...
Wyeth Lederle Vaccine's Prevnar(TM), First Vaccine for the Prevention of Invasive Pneumococcal Disease in Infants and Children, Recommended by...

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters